Today: 7 February 2026
Subscribe

Chubb Limited stock edges up as reinsurance renewal report flags lower prices; what CB investors watch next

Chubb Limited stock edges up as reinsurance renewal report flags lower prices; what CB investors watch next

NEW YORK, December 29, 2025, 23:10 ET — Market closed. Chubb Limited shares closed up 0.3% at $314.27 on Monday, holding up better than the broader U.S. market in thin year-end trading. The stock’s relative firmness came as insurance investors focused on the Jan. 1 reinsurance renewals after a new industry update pointed to easing prices. That matters now because Jan. 1 is the sector’s biggest annual reset for catastrophe reinsurance — insurance that insurers buy to cap big losses from events such as hurricanes and wildfires. The pricing and terms set this week can feed through to what carriers
30 December 2025
····
Deere stock ends higher as Wall Street slips; dividend date and Fed minutes in focus

Deere stock ends higher as Wall Street slips; dividend date and Fed minutes in focus

NEW YORK, December 29, 2025, 11:03 PM ET — Market closed Deere & Company (NYSE:DE) shares ended Monday higher, closing up 0.28% at $470.24. StockAnalysis The small gain stood out as U.S. stocks pulled back in thin, holiday-shortened trading, a period when year-end rebalancing can amplify moves in otherwise quiet tape. Reuters+1 Wall Street’s main indexes finished lower as megacap tech slid, and investors looked ahead to fresh signals on rates and growth. “This is (not) the beginning of the end of the tech dominance… it’ll turn out to be a buying opportunity,” said Hank Smith, director and head of
30 December 2025
·····
Intuit stock slips after co-founder Scott Cook trust files to sell $102 million stake

Intuit stock slips after co-founder Scott Cook trust files to sell $102 million stake

NEW YORK, December 29, 2025, 21:55 ET — Market closed. Intuit Inc. shares slipped on Monday after a regulatory filing showed co-founder and director Scott Cook’s family trust plans to sell a fresh block of stock. The TurboTax and QuickBooks maker ended down 0.35% at $674.15, tracking a softer tape for large-cap tech into the final week of the year. Finviz Why it matters now: insider sale notices can weigh on sentiment in thin, holiday-season trading, when modest flows can move prices more than usual. For Intuit, the filing lands as investors position for the peak U.S. tax-filing season, a
30 December 2025
·····
Palo Alto Networks stock dips as insider sales hit SEC filings; Fed minutes next

Palo Alto Networks stock dips as insider sales hit SEC filings; Fed minutes next

NEW YORK, December 29, 2025, 10:55 PM ET — Market closed Palo Alto Networks, Inc. (PANW) shares slipped 0.8% on Monday and closed at $186.85, after trading between $186.23 and $188.97. The disclosures matter in year-end trading, when liquidity can be thinner and investors react faster to new filings. The stock also trades as a high-growth software name, which can make it sensitive to shifts in interest-rate expectations. A filing showed chief financial officer Dipak Golechha sold 5,000 shares on Dec. 23 at $188.182 per share, leaving him with 155,119 shares. The filing said the sale was made under a
30 December 2025
·····
Stryker stock slips today as year-end trading turns cautious — dividend date and new COO in focus

Stryker stock slips today as year-end trading turns cautious — dividend date and new COO in focus

NEW YORK, December 29, 2025, 10:30 PM ET — Market closed Shares of Stryker Corp (SYK) ended Monday down 0.5% at $352.50, giving back ground as Wall Street slipped in the final week of 2025. The late-day drift mattered more than usual for a stock that has a near-term calendar: a shareholder record date for the next dividend lands this week, and Stryker’s new president and chief operating officer is set to take the role on Jan. 1. With trading volumes typically lighter around year-end, modest risk-off moves can show up quickly in large-cap healthcare names, especially after a tech-heavy
30 December 2025
·····
Novo Nordisk halves Wegovy prices in parts of China as copycat competition looms

Novo Nordisk halves Wegovy prices in parts of China as copycat competition looms

NEW YORK, December 29, 2025, 22:14 ET Novo Nordisk said it is lowering prices of its top-selling obesity drug Wegovy in China, after local outlet Yicai reported that list prices for the two highest doses were cut by 48% in the southwestern provinces of Yunnan and Sichuan. The new monthly list prices were 987 yuan ($141) and 1,284 yuan, Yicai said, citing local procurement authorities. Reuters The price move matters because China is fast becoming a pivotal growth market for weight-loss medicines, and pricing is now moving to the center of competition. Drugmakers are trying to lock in patients and
30 December 2025
····
Analog Devices stock slips into year-end as chip shares cool; Fed minutes and ADI earnings on deck

Analog Devices stock slips into year-end as chip shares cool; Fed minutes and ADI earnings on deck

NEW YORK, December 29, 2025, 10:34 PM ET — Market closed Analog Devices Inc shares fell 0.44% to close at $275.63 on Monday, tracking a softer session for semiconductors and the broader U.S. market. Texas Instruments dropped 0.67% and NXP Semiconductors slid 1.08%, while the S&P 500 ended down 0.35%. MarketWatch The late-December drift matters because thin, year-end trading can magnify price moves even when company news is scarce. “In light volume trading, we’re seeing a reversal of what we saw over the last couple of days,” said Rob Haworth, senior investment strategist at U.S. Bank Wealth Management. Reuters For
30 December 2025
·····
Lowe’s stock closes lower as Wall Street slips; housing data and Fed minutes in focus

Lowe’s stock closes lower as Wall Street slips; housing data and Fed minutes in focus

NEW YORK, December 29, 2025, 10:26 PM ET — Market closed. Lowe’s Companies Inc shares finished Monday down 0.14% at $243.48. The stock was last indicated at $243.83 in after-hours trading. Yahoo Finance The move kept Lowe’s near a level investors have treated as a referendum on the U.S. housing cycle and interest-rate direction. Home-improvement spending can firm when mortgage rates ease and housing turnover rises, but it tends to stall when homeowners delay big projects. Housing data delivered a fresh data point late in the session. Contracts to buy existing homes — known as pending home sales, a gauge
30 December 2025
·····
Boston Scientific (BSX) stock slips in year-end pullback; February earnings loom

Boston Scientific (BSX) stock slips in year-end pullback; February earnings loom

NEW YORK, December 29, 2025, 10:27 PM ET — Market closed Boston Scientific shares closed down 0.3% at $95.76 on Monday. The stock traded between $95.53 and $96.64, with about 5.4 million shares changing hands. StockAnalysis The modest move still matters now because thin year-end liquidity can magnify small shifts in positioning. For large-cap healthcare names like Boston Scientific, traders are also watching whether defensive sectors can stay steady as leadership narrows in the final stretch of 2025. Wall Street’s main indexes finished lower, with the Dow down 0.51%, the S&P 500 off 0.35% and the Nasdaq down 0.50%, according
30 December 2025
·····
Gilead stock nudges up after Bernstein flags limited Medicaid pricing hit

Gilead stock nudges up after Bernstein flags limited Medicaid pricing hit

NEW YORK, December 29, 2025, 22:17 ET — Market closed Gilead Sciences (GILD.O) shares were last up 0.15% at $124.91 on Monday, as investors weighed an analyst note that argued new Medicaid drug-pricing rules would have a limited financial impact on the company’s HIV franchise. Investing.com The call matters now because drugmakers and investors are still parsing a Trump administration pricing push that targets Medicaid and aims to bring U.S. medicine prices closer to those in other wealthy countries. Reuters For Gilead, the focus has been on whether “most-favored-nation” pricing — a policy that effectively ties prices to lower international
30 December 2025
·····
Danaher stock beats Wall Street dip as investors eye Fed minutes and Jan. 28 earnings

Danaher stock beats Wall Street dip as investors eye Fed minutes and Jan. 28 earnings

NEW YORK, December 29, 2025, 22:23 ET — Market closed Danaher Corp shares were last up about 0.1% at $230.63 on Monday, after trading between $229.26 and $231.77 during the session. The muted move still mattered for Danaher investors because the stock held up in a market that turned lower as the year winds down and liquidity thins, a setup that can amplify sector rotations. It also comes ahead of a key macro catalyst: the Federal Reserve’s December meeting minutes, due Tuesday, with traders pricing in additional rate cuts in 2026 as the U.S. dollar weakens into year-end. reuters.com U.S.
30 December 2025
·····
Amgen stock slips to $330 as year-end pullback hits Wall Street; Fed minutes and MariTide updates in focus

Amgen stock slips to $330 as year-end pullback hits Wall Street; Fed minutes and MariTide updates in focus

NEW YORK, December 29, 2025, 22:14 ET — Market closed Amgen shares fell 1% on Monday, ending the session down $3.30 at $329.63. StockAnalysis The decline matters now because traders are heading into the final sessions of the year with U.S. indexes near record territory and liquidity thinner than usual. That backdrop can amplify moves in large-cap healthcare stocks even without a company-specific trigger. Reuters Wall Street’s main indexes closed lower, led by a retreat in heavyweight technology names, Reuters reported. “It’ll turn out to be a buying opportunity,” said Hank Smith, director and head of investment strategy at Haverford
30 December 2025
·····
1 … 1,104 1,105 1,106 1,107 1,108 … 2,712

Stock Market Today

Meta stock faces an AI split: ad gains vs a $135 billion bill

Meta stock faces an AI split: ad gains vs a $135 billion bill

7 February 2026
Meta shares dropped 1.3% to $661.46 on Friday after the company projected 2026 capital spending of up to $135 billion, raising investor concerns over cash flow. Meta reported Q4 revenue of $59.89 billion, up 24% year-over-year, with ad impressions rising 18%. Analysts remain divided on whether AI-driven ad gains can offset the steep spending ramp.
IAG share price jumps toward a 52-week peak — what to watch before London reopens

IAG share price jumps toward a 52-week peak — what to watch before London reopens

7 February 2026
IAG shares rose 4.33% to 438.50 pence Friday, near their 52-week high, ahead of full-year results due later this month. The company reported 162,073,135 treasury shares and total voting rights of 4,565,128,012. Brent crude fell 2.2% Thursday to $67.93 a barrel. South Europe Ground Services logged 712,340 operations in 2025 and seeks approval to operate in Portugal.
Go toTop